Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor class drugs

5 results

  • abacavir and lamivudine

    (Abacavir and Lamivudine)
    Laurus Labs Limited
    Abacavir and lamivudine tablets are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection when used in combination with other antiretroviral agents.
    Medication Details
    Drug Interactions

  • delstrigo

    (doravirine, lamivudine, and tenofovir disoproxil fumarate)
    Merck Sharp & Dohme LLC
    DELSTRIGO® is indicated for the treatment of HIV-1 infection in adults and pediatric patients weighing at least 35 kg, either as a complete regimen for those with no prior antiretroviral treatment or to replace the current regimen in patients who are virologically suppressed with no history of treatment failure.
    Medication Details
    Drug Interactions

  • dovato

    (dolutegravir sodium and lamivudine)
    ViiV Healthcare Company
    DOVATO is indicated for the treatment of HIV-1 infection in adults and adolescents (aged 12 and older, weighing at least 25 kg) either as a complete regimen for those with no prior treatment history or to replace the current regimen in virologically suppressed patients without resistance concerns.
    Medication Details
    Drug Interactions

  • lamivudine

    (lamivudine oral)
    Chartwell RX, LLC
    Lamivudine oral solution is indicated in combination with other antiretroviral agents for treating HIV-1 infection. It is not intended for use in hepatitis B virus (HBV) treatment.
    Medication Details
    Drug Interactions

  • triumeq

    (abacavir sulfate, dolutegravir sodium, lamivudine)
    ViiV Healthcare Company
    TRIUMEQ and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and pediatric patients aged at least 3 months and weighing at least 6 kg. They are not recommended for patients with integrase resistance or suspected INSTI resistance due to insufficient dolutegravir dosage.
    Medication Details
    Drug Interactions